Plano Matthew T.'s Form 4 filing
Abiomed IncABMD · filed Nov 3, 2022
- Accession no.
- 0001415889-22-011065
- Filed
- Nov 3, 2022
- Trade date
- Nov 1, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.34M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Plano Matthew T.CIK 0001931998 | Officer (VP, GLOBAL OPERATIONS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2022 | Common Stock $.01 par value | MOption exerciseAcquired | +1,843 | $223.90 | +$412,647.7 | 13,814 | Direct | |
| Nov 1, 2022 | Common Stock $.01 par value | SSaleDisposed | −974 | $377.84F3 | −$368,016.16 | 12,840 | Direct | |
| Nov 1, 2022 | Common Stock $.01 par value | SSaleDisposed | −1,699 | $378.61F4 | −$643,258.39 | 11,141 | Direct | |
| Nov 1, 2022 | Common Stock $.01 par value | SSaleDisposed | −722 | $379.33F5 | −$273,876.26 | 10,419 | Direct | |
| Nov 1, 2022 | Common Stock $.01 par value | SSaleDisposed | −149 | $380.22F6 | −$56,652.78 | 10,270 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2022 | Common Stock | MOption exerciseDisposed | 0 | $0.00 | $0 | 922 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This price represents the sale price of the transactions on the reported date at $377.8389. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F4
This price represents the sale price of the transactions on the reported date at $378.6120. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F5
This price represents the sale price of the transactions on the reported date at $379.3305. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F6
This price represents the sale price of the transactions on the reported date at $380.2151. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.